Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Şermin Bilgen Ulgar & Hamza Ayaydın. (2018) Hyperprolactinaemia and menstrual irregularity emerging in association with risperidone use and treated with aripiprazole in an adolescent diagnosed with schizophrenia: a case report. Psychiatry and Clinical Psychopharmacology 28:4, pages 469-472.
Read now
Read now
Andrea McCloughen, Kim Foster, Nikka Marabong, David Miu & Judith Fethney. (2015) Physical Health Risk Behaviours in Young People with Mental Illness. Issues in Mental Health Nursing 36:10, pages 781-790.
Read now
Read now
Afshan A Khan, Jeffrey R Strawn & Paul E Croarkin. (2010) Emerging treatment options in bipolar disorder in adolescents: focus on ziprasidone. Adolescent Health, Medicine and Therapeutics 1, pages 137-143.
Read now
Read now
Todd Lencz & Anil K. Malhotra. (2009) Pharmacogenetics of antipsychotic-induced side effects. Dialogues in Clinical Neuroscience 11:4, pages 405-415.
Read now
Read now
Articles from other publishers (58)
Nirmal Singh, Natasha Sood & Taranjeet Jolly. (2021) Perphenazine-Associated Nausea. Journal of Clinical Psychopharmacology 41:5, pages 606-608.
Crossref
Crossref
Jennifer D. HaydenLibby HorterTaft Parsons, III, IIIMatthew RubleSabrina TownsendChristina C. KleinRodrigo Patino DuranJeffrey A. WelgeStephen CrystalNick C. PatelChristoph U. CorrellMelissa P. DelBello. (2020) Metabolic Monitoring Rates of Youth Treated with Second-Generation Antipsychotics in Usual Care: Results of a Large US National Commercial Health Plan. Journal of Child and Adolescent Psychopharmacology 30:2, pages 119-122.
Crossref
Crossref
Thomas I. Mackie, Sharon Cook, Stephen Crystal, Mark Olfson & Ayse Akincigil. (2020) Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention. Journal of the American Academy of Child & Adolescent Psychiatry 59:1, pages 166-176.e3.
Crossref
Crossref
Keunhye Park, Nathanael J. Okpych & Mark E. Courtney. (2019) Psychotropic Medication Use and Perceptions of Medication Effects Among Transition-Age Foster Youth. Child and Adolescent Social Work Journal 36:6, pages 583-597.
Crossref
Crossref
Ishita Kharode, Emily Coppedge & Zoltan Antal. (2019) Care of Children and Adolescents with Diabetes Mellitus and Hyperglycemia in the Inpatient Setting. Current Diabetes Reports 19:10.
Crossref
Crossref
Claudine Higdon, Rebecca M. Eichenbaum & Melissa P. DelBello. 2019. Psychiatric Nonadherence. Psychiatric Nonadherence
191
200
.
Natalia E. Uzal, Benjamin Chavez, Emily R. Kosirog, Sarah J. Billups & Joseph J. Saseen. (2017) Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers. Annals of Pharmacotherapy 52:2, pages 160-165.
Crossref
Crossref
Mikhail S. Zastrozhin, Dmitry A. Sychev, Elena A. Grishina, Ludmila M. Savchenko & Evgeny A. Bryun. (2017) Pharmacodynamic gene polymorphism and adverse drug reactionsthen applying antipsychotic drugs. World Journal of Personalized Medicine 1:1, pages 5-12.
Crossref
Crossref
Daryl Efron, Margie H Danchin, Noel E Cranswick, Alisha Gulenc, Stephen Hearps & Harriet Hiscock. (2017) Medication prescribed by Australian paediatricians: Psychotropics predominate. Journal of Paediatrics and Child Health 53:10, pages 957-962.
Crossref
Crossref
Emilia MateraLucia MargariVincenzo Ostilio PalmieriGiuseppina ZagariaRoberto PalumbiFrancesco Margari. (2017) Risperidone and Cardiometabolic Risk in Children and Adolescents. Journal of Clinical Psychopharmacology 37:3, pages 302-309.
Crossref
Crossref
Ronald W. Thompson, Kristin Duppong Hurley, Alexandra L. Trout, Jonathan C. Huefner & Daniel L. Daly. (2017) Closing the Research to Practice Gap in Therapeutic Residential Care. Journal of Emotional and Behavioral Disorders 25:1, pages 46-56.
Crossref
Crossref
Thomas I. Mackie, Justeen Hyde, Lawrence A. Palinkas, Emily Niemi & Laurel K. Leslie. (2016) Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States’ Monitoring Mechanisms. Administration and Policy in Mental Health and Mental Health Services Research 44:2, pages 243-257.
Crossref
Crossref
James H Flory, Jason Roy, Joshua J Gagne, Kevin Haynes, Lisa Herrinton, Christine Lu, Elisabetta Patorno, Azadeh Shoaibi & Marsha A Raebel. (2017) Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. Journal of Comparative Effectiveness Research 6:1, pages 25-32.
Crossref
Crossref
Christopher BellonciMegan BakerJonathan C. HuefnerRobert J. Hilt. (2016) Deprescribing and Its Application to Child Psychiatry. Child and Adolescent Psychopharmacology News 21:6, pages 1-9.
Crossref
Crossref
Noa TsujiiTakuya SaitoYuji IzumotoMasahide UsamiTakashi OkadaHideki NegoroJunzo Iida. (2016) Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan. Journal of Child and Adolescent Psychopharmacology 26:7, pages 642-645.
Crossref
Crossref
Marsha A. Raebel, Susan Shetterly, Christine Y. Lu, James Flory, Joshua J. Gagne, Frank E. Harrell, Kevin Haynes, Lisa J. Herrinton, Elisabetta Patorno, Jennifer Popovic, Mano Selvan, Azadeh Shoaibi, Xingmei Wang & Jason Roy. (2016) Methods for using clinical laboratory test results as baseline confounders in multi‐site observational database studies when missing data are expected. Pharmacoepidemiology and Drug Safety 25:7, pages 798-814.
Crossref
Crossref
Marie-Line Menard, Susanne Thümmler, Marianna Giannitelli, Bertrand Olliac, Olivier Bonnot, David Cohen & Florence Askenazy. (2016) Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE). BMJ Open 6:4, pages e011020.
Crossref
Crossref
Jiamei Lian, Xu-Feng Huang, Nagesh Pai & Chao Deng. (2016) Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Pharmacological Research 106, pages 51-63.
Crossref
Crossref
Jarrett Barnhill. 2016. Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. Health Care for People with Intellectual and Developmental Disabilities across the Lifespan
1585
1600
.
Kirsi-Maria Haapasalo-Pesu, Max Karukivi & Simo Saarijärvi. (2015) The Growing Trend of Prescribing Antipsychotics for Young People in Finland, 2000 to 2010. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology 4:1, pages 31-35.
Crossref
Crossref
M.-L. Menard, F. Askenazy, P. Auby, O. Bonnot & D. Cohen. (2015) Améliorer la surveillance de la tolérance pédiatrique des antipsychotiques en France. Archives de Pédiatrie 22:1, pages 92-97.
Crossref
Crossref
Rebecca Ronsley, Lorrie Chow, Kristine Kuss, Jana Davidson & Constadina Panagiotopoulos. 2015. The Science and Ethics of Antipsychotic Use in Children. The Science and Ethics of Antipsychotic Use in Children
65
90
.
Emily Kline, Elizabeth C. Thompson, Camille S. Wilson, Sabrina Ereshefsky, Gloria Reeves & Jason Schiffman. 2015. Handbook of Adolescent Behavioral Problems. Handbook of Adolescent Behavioral Problems
361
380
.
Marsha A. RaebelRobert PenfoldAnn W. McMahon, Marsha ReichmanSusan ShetterlyGlenn GoodrichSusan AndradeChristoph U. Correll & Tobias Gerhard. (2014) Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics. Pediatrics 134:5, pages e1308-e1314.
Crossref
Crossref
Jo Richards. (2018) Medication management following first-episode psychosis in young people: a developmental approach. Advances in Psychiatric Treatment 20:5, pages 314-322.
Crossref
Crossref
Amanda R. Kreider, Meredith Matone, Christopher Bellonci, Susan dosReis, Chris Feudtner, Yuan-Shung Huang, Russell Localio & David M. Rubin. (2014) Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children. Journal of the American Academy of Child & Adolescent Psychiatry 53:9, pages 960-970.e2.
Crossref
Crossref
Jiamei Lian, Xu-Feng Huang, Nagesh Pai & Chao Deng. (2014) Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment. PLoS ONE 9:8, pages e104160.
Crossref
Crossref
Carolina Schneider, David Taylor, Gil Zalsman, Sophia Frangou & Marinos Kyriakopoulos. (2014) Antipsychotics use in children and adolescents: An on-going challenge in clinical practice. Journal of Psychopharmacology 28:7, pages 615-623.
Crossref
Crossref
Presenters: Anne M. WhiteRajinderpal SinghTheodor RaisDiscussant: Barbara J. Coffey. (2014) Premature Thelarche in an 8-Year-Old Girl Following Prolonged Use of Risperidone. Journal of Child and Adolescent Psychopharmacology 24:4, pages 228-230.
Crossref
Crossref
Jonathan C. Huefner & Annette K. Griffith. (2014) Psychotropic Medication Use with Troubled Children and Youth. Journal of Child and Family Studies 23:4, pages 613-616.
Crossref
Crossref
Emily Kline, Danielle Denenny, Gloria Reeves & Jason Schiffman. 2014. Handbook of School Mental Health. Handbook of School Mental Health
323
338
.
Robert L. FindlingIdil ÇavuşElizabeth PappadopulosDouglas G. VanderburgJeffrey H. SchwartzBalarama K. GundapaneniMelissa P. DelBello. (2013) Efficacy, Long-Term Safety, and Tolerability of Ziprasidone in Children and Adolescents with Bipolar Disorder. Journal of Child and Adolescent Psychopharmacology 23:8, pages 545-557.
Crossref
Crossref
Christopher Bellonci, Jonathan C. Huefner, Annette K. Griffith, Georgi Vogel-Rosen, Gail L. Smith & Scott Preston. (2013) Concurrent reductions in psychotropic medication, assault, and physical restraint in two residential treatment programs for youth. Children and Youth Services Review 35:10, pages 1773-1779.
Crossref
Crossref
Mary Jayne Kennedy, Kevin D. Jellerson, Michael Z. Snow & Michelle L. Zacchetti. (2013) Challenges in the Pharmacologic Management of Obesity and Secondary Dyslipidemia in Children and Adolescents. Pediatric Drugs 15:5, pages 335-342.
Crossref
Crossref
Yvette Roke, Peter N. van Harten, Barbara Franke, Tessel E. Galesloot, Annemieke M. Boot & Jan K. Buitelaar. (2013) The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys. Pharmacogenetics and Genomics 23:9, pages 487-493.
Crossref
Crossref
Lewis Couchman, Sally V.J. Bowskill, Simon Handley, Maxine X. Patel & Robert J. Flanagan. (2013) Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010. Early Intervention in Psychiatry 7:2, pages 122-130.
Crossref
Crossref
L. Oriana Linares, Nuria Martinez-Martin & F. Xavier Castellanos. (2013) Stimulant and Atypical Antipsychotic Medications For Children Placed in Foster Homes. PLoS ONE 8:1, pages e54152.
Crossref
Crossref
Gahan Pandina, Stuart Kushner, Keith Karcher & Magali Haas. (2012) An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia. Child and Adolescent Psychiatry and Mental Health 6:1.
Crossref
Crossref
Yvette RokeJan K. BuitelaarAnnemieke M. BootDiederik TenbackPeter N. van Harten. (2012) Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone. Journal of Child and Adolescent Psychopharmacology 22:6, pages 432-439.
Crossref
Crossref
Meredith Matone, Russell Localio, Yuan‐Shung Huang, Susan dosReis, Chris Feudtner & David Rubin. (2012)
The Relationship between Mental Health Diagnosis and Treatment with Second‐Generation Antipsychotics over Time: A National Study of
U.S.
Medicaid‐Enrolled Children
. Health Services Research 47:5, pages 1836-1860.
Crossref
Crossref
Tamara Pringsheim, Constadina Panagiotopoulos, Jana Davidson & Josephine Ho. (2012) Des recommandations probantes pour surveiller l’innocuité des antipsychotiques de deuxième génération chez les enfants et les adolescents. Paediatrics & Child Health 17:suppl_B, pages 12B-21B.
Crossref
Crossref
Chao Deng, Jiamei Lian, Nagesh Pai & Xu-Feng Huang. (2012) Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model. Journal of Psychopharmacology 26:9, pages 1271-1279.
Crossref
Crossref
David Rubin, Meredith Matone, Yuan-Shung Huang, Susan dosReis, Chris Feudtner & Russell Localio. (2012) Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review 34:8, pages 1492-1499.
Crossref
Crossref
Satabdi Chatterjee, Hua Chen, Michael L. Johnson & Rajender R. Aparasu. (2012) Risk of Falls and Fractures in Older Adults Using Atypical Antipsychotic Agents: A Propensity Score–Adjusted, Retrospective Cohort Study. The American Journal of Geriatric Pharmacotherapy 10:2, pages 83-94.
Crossref
Crossref
Mini Tandon & Joan Luby. 2012. Pharmacotherapy of Child and Adolescent Psychiatric Disorders. Pharmacotherapy of Child and Adolescent Psychiatric Disorders
399
420
.
Amal Abdel-Baki, Clairélaine Ouellet-Plamondon & Ashok Malla. (2012) Pharmacotherapy challenges in patients with first-episode psychosis. Journal of Affective Disorders 138, pages S3-S14.
Crossref
Crossref
Lutz Goldbeck, Paul L. Plener, Franz Resch & Jörg M. Fegert. 2012. Psychiatrie und Psychotherapie des Kindes- und Jugendalters. Psychiatrie und Psychotherapie des Kindes- und Jugendalters
177
224
.
Michael G. Kölch, Paul L. Plener & Jörg M. Fegert. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
1185
1198
.
Tamara Pringsheim, Constadina Panagiotopoulos, Jana Davidson & Josephine Ho. (2011) Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth. Paediatrics & Child Health 16:9, pages 581-589.
Crossref
Crossref
M. De Hert, D. Vancampfort, C. U. Correll, V. Mercken, J. Peuskens, K. Sweers, R. van Winkel & A. J. Mitchell. (2018) Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. British Journal of Psychiatry 199:2, pages 99-105.
Crossref
Crossref
M. de Hert, M. Dobbelaere, E.M. Sheridan, D. Cohen & C.U. Correll. (2011) Efectos adversos metabólicos y endocrinos de los antipsicóticos de segunda generación en niños y adolescentes: una revisión sistemática de ensayos aleatorizados, controlados con placebo y guías de práctica clínica. Psiquiatría Biológica 18:3, pages 89-104.
Crossref
Crossref
M. De Hert, M. Dobbelaere, E.M. Sheridan, D. Cohen & C.U. Correll. (2020) Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice. European Psychiatry 26:3, pages 144-158.
Crossref
Crossref
Elaine H. Morrato, Benjamin G. Druss, Daniel M. Hartung, Robert J. Valuck, Deborah Thomas, Richard Allen, Elizabeth Campagna & John W. Newcomer. (2010) Small area variation and geographic and patient‐specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiology and Drug Safety 20:1, pages 66-75.
Crossref
Crossref
Moogeh Baharnoori, Cali Bartholomeusz, Aurelie A. Boucher, Lisa Buchy, Christopher Chaddock, Bonga Chiliza, Melanie Föcking, Alex Fornito, Juan A. Gallego, Hiroaki Hori, Gisele Huf, Gul A. Jabbar, Shi Hyun Kang, Yousri El Kissi, Jessica Merchán-Naranjo, Gemma Modinos, Nashaat A.M. Abdel-Fadeel, Anna-Karin Neubeck, Hsiao Piau Ng, Gabriela Novak, Olasunmbo O. Owolabi, Diana P. Prata, Naren P. Rao, Igor Riecansky, Darryl C. Smith, Renan P. Souza, Renate Thienel, Hanan D. Trotman, Hiroyuki Uchida, Kristen A. Woodberry, Anne O'Shea & Lynn E. DeLisi. (2010) The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions. Schizophrenia Research 124:1-3, pages e1-e62.
Crossref
Crossref
Jiamei Lian, Xu-Feng Huang, Nagesh Pai & Chao Deng. (2010) Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:6, pages 1157-1158.
Crossref
Crossref
Anand K Mattai, Julia L Hill & Rhoshel K Lenroot. (2010) Treatment of early-onset schizophrenia. Current Opinion in Psychiatry 23:4, pages 304-310.
Crossref
Crossref
Julie B. PenznerMelissa DudasEma SaitoVladimir OlshanskiyUmesh H. ParikhSandeep KapoorRaja ChekuriDominick GadaletaJennifer AvedonEva M. SheridanJane RandellAnil K. MalhotraJohn M. KaneChristoph U. Correll. (2009) Lack of Effect of Stimulant Combination with Second-Generation Antipsychotics on Weight Gain, Metabolic Changes, Prolactin Levels, and Sedation in Youth with Clinically Relevant Aggression or Oppositionality. Journal of Child and Adolescent Psychopharmacology 19:5, pages 563-573.
Crossref
Crossref
Yvette RokePeter N. van HartenAnnemieke M. BootJan K. Buitelaar. (2009) Antipsychotic Medication in Children and Adolescents: A Descriptive Review of the Effects on Prolactin Level and Associated Side Effects. Journal of Child and Adolescent Psychopharmacology 19:4, pages 403-414.
Crossref
Crossref